Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated just now
Peer-reviewedCC BY 4.0Frontiers in Immunology

Decoding pyroptosis at single-cell resolution: heterogeneity, microenvironment remodeling and potential translational insights

  1. 1Department of Pathology, Renmin Hospital of Wuhan University
  2. 2Department of Pathology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology

Abstract

Pyroptosis, a pro-inflammatory programmed cell death mediated by inflammatory caspases and Gasdermin (GSDM) family proteins, exerts dual roles in host defense and pathological damage. Traditional bulk RNA sequencing (bulk RNA-seq) is limited in capturing single-cell heterogeneity and dissecting intercellular communication, impeding in-depth mechanistic exploration of pyroptosis. Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool to address these limitations, enabling high-throughput profiling of single-cell transcriptomes and precise characterization of gene expression heterogeneity, cell subset features, and putative intercellular interaction networks. Here, we comprehensively summarize the cutting-edge applications of scRNA-seq in pyroptosis research from four core aspects: (1) dissecting pyroptosis-related transcriptional heterogeneity with cell subtype and state specificity across diverse cell types and diseases; (2) exploring candidate mechanisms underlying pyroptosis-associated microenvironment remodeling (including immune polarization and stromal reorganization) in pathological progression; (3) harnessing scRNA-seq to construct prognostic pyroptosis-related gene signatures (PRGS) for candidate risk stratification via integration with bulk RNA-seq data; and (4) putative targeted therapeutic strategies (preclinical-stage evidence), including modulation of core pyroptotic nodes, regulation of endogenous modulators, exploitation of exogenous compounds, and indirect interventions through cell function optimization or gut microbiota modulation. Future research should integrate scRNA-seq with multi-omics technologies to construct a multi-dimensional pyroptosis regulatory network, thereby supporting the preclinical development and potential clinical translation of pyroptosis-targeted therapies for inflammation-associated diseases and tumors.

Related

  1. METTL family proteins: functional heterogeneity, tumor regulatory networks, immune microenvironment remodeling and therapeutic potential
    Qiujie Ding, Peng Wang, Hailong Yu +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMCPMC
  2. Targeting lysine acetyltransferase 6A/B in cancer: a conceptual and translational review of epigenetic regulation, immune microenvironment remodeling, and the dual-compartment hypothesis
    Cong Ma, Jingru Wang, Guanhua Qiao +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  3. Exercise-Mediated Regulation of Pyroptosis in Diabetes and Its Complications: Molecular Mechanisms and Translational Perspectives
    Junzhe Li, Ze Wang, Danlin Zhu +2
    BiomoleculesPeer-reviewedCC BY 4.0General biochemistryCrossref
  4. TENASCIN-Dependent Mesenchymal–Epithelial Interactions Associated with Interstitial Microenvironment Remodeling in Cattle-Yak Lung: Insights from Single-Nucleus Transcriptomics
    Qianyun Ge, Jie Pei, Lin Xiong +2
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  5. 71 Spatial analysis of tumor microenvironment remodeling during non-small cell lung cancer progression
    Thang Tran, Julie Nguyen, Junya Yoshioka +6
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
BibTeX
@article{xiang2026decoding,
  title = {{Decoding pyroptosis at single-cell resolution: heterogeneity, microenvironment remodeling and potential translational insights}},
  author = {Lingyan Xiang and Na Tang and Yaqi Deng and Jingping Yuan and Jie Rao and Aolong Ma and Qianwen Wang and Li Xu and Lina Zhao and Honglin Yan},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1869338},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1869338/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Decoding pyroptosis at single-cell resolution: heterogeneity, microenvironment remodeling and potential translational insights
AU  - Lingyan Xiang
AU  - Na Tang
AU  - Yaqi Deng
AU  - Jingping Yuan
AU  - Jie Rao
AU  - Aolong Ma
AU  - Qianwen Wang
AU  - Li Xu
AU  - Lina Zhao
AU  - Honglin Yan
PY  - 2026
DA  - 2026/10/22
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1869338
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1869338/full
AB  - Pyroptosis, a pro-inflammatory programmed cell death mediated by inflammatory caspases and Gasdermin (GSDM) family proteins, exerts dual roles in host defense and pathological damage. Traditional bulk RNA sequencing (bulk RNA-seq) is limited in capturing single-cell heterogeneity and dissecting intercellular communication, impeding in-depth mechanistic exploration of pyroptosis. Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool to address these limitations, enabling high-throughput profiling of single-cell transcriptomes and precise characterization of gene expression heterogeneity, cell subset features, and putative intercellular interaction networks. Here, we comprehensively summarize the cutting-edge applications of scRNA-seq in pyroptosis research from four core aspects: (1) dissecting pyroptosis-related transcriptional heterogeneity with cell subtype and state specificity across diverse cell types and diseases; (2) exploring candidate mechanisms underlying pyroptosis-associated microenvironment remodeling (including immune polarization and stromal reorganization) in pathological progression; (3) harnessing scRNA-seq to construct prognostic pyroptosis-related gene signatures (PRGS) for candidate risk stratification via integration with bulk RNA-seq data; and (4) putative targeted therapeutic strategies (preclinical-stage evidence), including modulation of core pyroptotic nodes, regulation of endogenous modulators, exploitation of exogenous compounds, and indirect interventions through cell function optimization or gut microbiota modulation. Future research should integrate scRNA-seq with multi-omics technologies to construct a multi-dimensional pyroptosis regulatory network, thereby supporting the preclinical development and potential clinical translation of pyroptosis-targeted therapies for inflammation-associated diseases and tumors.
SN  - 1664-3224
ER  -